Corneal permeation properties of a charged lipid nanoparticle carrier containing dexamethasone. - Wikidata - awgldk - TriplyDB

Corneal permeation properties of a charged lipid nanoparticle carrier containing dexamethasone.

Corneal permeation properties of a charged lipid nanoparticle carrier containing dexamethasone.

http://www.wikidata.org/entity/Q37652843

about

Nanoparticles for drug delivery to the anterior segment of the eye.Dendrimers for Ocular Drug Delivery.Functional intercalated nanocomposites with chitosan-glutathione-glycylsarcosine and layered double hydroxides for topical ocular drug delivery.

P2860

Q39230212-F0800157-5CA3-4E72-AAA3-C416D025C7FF Q45073183-C62B2635-A09D-4F7B-A5D1-895BD2C6EE36 Q50335529-A3862B0D-638F-40B1-9E20-6F95D6DE6A53

P2860

Corneal permeation properties of a charged lipid nanoparticle carrier containing dexamethasone.

http://www.wikidata.org/entity/Q37652843

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Corneal permeation properties ...... rier containing dexamethasone.

@en

Corneal permeation properties ...... rier containing dexamethasone.

@nl

type

label

Corneal permeation properties ...... rier containing dexamethasone.

@en

Corneal permeation properties ...... rier containing dexamethasone.

@nl

prefLabel

Corneal permeation properties ...... rier containing dexamethasone.

@en

Corneal permeation properties ...... rier containing dexamethasone.

@nl

P1433

Q37652843-934F57FC-A9D8-4448-BFA2-993FA2F490A1

P1476

Q37652843-424889F8-7D11-42E9-8590-3B50F675C43C

P2093

Q37652843-2FCD6EBB-D6A3-4824-B56E-EE0280705ED0

Q37652843-3A09114B-6FB9-4187-881D-ED315EFF246E

Q37652843-415130E0-8834-4EBE-ADC4-6B8EB992B713

Q37652843-6427D5F7-5E8B-4705-86ED-75BA7C2485E9

Q37652843-799DF8FF-80F8-49E2-9A6E-6F87C1378AED

Q37652843-83DFAF54-6F21-48C2-9A86-32D8D1B59B72

Q37652843-EE9AABCB-920E-44C1-9B4E-0F15A2712BD4

P2860

Q37652843-0272E38D-01B2-4837-B5DD-1CA06686F145

Q37652843-0A9481C1-0818-4C2D-B2E1-6A65ABEEDA14

Q37652843-0E91CE20-792A-4268-88D9-4F4E7CC92596

Q37652843-0F6E7EEA-A006-4E9D-8DAD-D7D429D2AD84

Q37652843-174392B5-1E87-49D1-B84E-DCBB6A99A175

Q37652843-2B9C33B3-D208-44E5-B6CA-1A6C30C6FDC6

Q37652843-2E444317-7F0A-44AC-B333-1A87E4F0D494

Q37652843-2E92CB6A-D644-4925-AF51-6CF74EB60F58

Q37652843-3C511F89-7654-4165-8AFB-A64384170B6A

Q37652843-439CC26A-85DB-46C1-B468-E3A409CD25EE

P304

Q37652843-BF679053-20A7-413E-8B2E-94A02F319E2C

P31

Q37652843-8C561EA7-A87A-4B09-94B8-D797597CC440

P356

Q37652843-35BACC38-2A96-4515-B661-C3357C2E0F1C

P407

Q37652843-E8E811AA-612E-4560-A376-37102345EAB4

P478

Q37652843-FC8788C7-FE80-48D0-968F-4F464144012E

P577

Q37652843-DFD7A77B-850A-40FD-98E4-E144073EC545

P698

Q37652843-24915F50-F06C-4E10-BA42-1033E9E9136A

P921

Q37652843-7345F222-6C7C-4E47-9F86-576543B4BF62

Q37652843-A5B3D596-7435-4F95-9135-9EF7B130C021

P932

Q37652843-FE563905-DEF3-444C-8CC5-DF043B374C7C

P356

P1433

International Journal of Nanomedicine

P1476

Corneal permeation properties ...... rier containing dexamethasone.

@en

P2093

Dongzhi Hou

http://www.w3.org/2001/XMLSchema#string

Guanghan Deng

http://www.w3.org/2001/XMLSchema#string

Junfeng Ban

http://www.w3.org/2001/XMLSchema#string

Xin Huang

http://www.w3.org/2001/XMLSchema#string

Yan Zhang

http://www.w3.org/2001/XMLSchema#string

Yanzhong Chen

http://www.w3.org/2001/XMLSchema#string

Zhufen Lu

http://www.w3.org/2001/XMLSchema#string

P2860

Stimuli-Responsive Polymeric Systems for Controlled Protein and Peptide Delivery: Future Implications for Ocular Delivery

Improvements in Topical Ocular Drug Delivery Systems: Hydrogels and Contact Lenses

Comparison of topical 0.7% dexamethasone-cyclodextrin with 0.1% dexamethasone sodium phosphate for postcataract inflammation.

Enhancement of ocular drug penetration.

Topical delivery of aceclofenac: challenges and promises of novel drug delivery systems.

Cyclodextrins in ophthalmic drug delivery.

Microemulsions as ocular drug delivery systems: recent developments and future challenges.

Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery.

Ocular preparations: the formulation approach.

Cross-linking with ultraviolet-a and riboflavin reduces corneal permeability

P304

1329-1339

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJN.S126199

http://www.w3.org/2001/XMLSchema#string

P407

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28243093

http://www.w3.org/2001/XMLSchema#string

P921

P932

5317251

http://www.w3.org/2001/XMLSchema#string